Injection Drug Users and the Provision of Hepatitis C-Related Services in a Nationwide Sample of Drug Treatment Programs

Zdravko P. Vassilev, Shiela M. Strauss, Janetta Astone, Don C. Des Jarlais

Research output: Contribution to journalArticle


Drug treatment facilities are important sites for providing targeted prevention and health services to injection drug users (IDUs) who are infected with the hepatitis C virus (HCV). A nationwide survey was conducted to examine whether differences exist in the HCV-related services provided by drug treatment programs that have varying proportions of IDUs among their patients. The results indicate that, overall, drug treatment programs with a greater proportion of IDUs offer significantly more HCV services as compared to programs with a smaller proportion of IDUs. However, important components of hepatitis C-related care, such as universal basic education and counseling about HCV and extensive HCV-antibody testing, are not yet being provided by all programs with a large proportion of IDUs among their patient populations.

Original languageEnglish (US)
Pages (from-to)208-216
Number of pages9
JournalJournal of Behavioral Health Services and Research
Issue number2
StatePublished - Apr 1 2004


ASJC Scopus subject areas

  • Health(social science)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this